Aquaporin-4 Genetics, Sleep, and Brain Atrophy: Untangling a New Web in Alzheimer’s Disease

Alzheimer’s genetic risk has typically meant APOE and little else in the clinical vernacular, but this new data highlights AQP4—key to glymphatic function and, plausibly, amyloid clearance. When layered with self-reported sleep parameters, certain AQP4 variants tracked not only with AD-relevant brain changes (regional atrophy, volume loss) but also with a steeper cognitive slide in those with disturbed sleep. No one’s counseling patients on AQP4 testing or tweaking sleep based on SNPs yet, but this points toward a risk stratification model that incorporates both chronic sleep issues and underlying genetics.